1. Home
  2. RLMD vs ZEUS Comparison

RLMD vs ZEUS Comparison

Compare RLMD & ZEUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • ZEUS
  • Stock Information
  • Founded
  • RLMD 2004
  • ZEUS 1954
  • Country
  • RLMD United States
  • ZEUS United States
  • Employees
  • RLMD N/A
  • ZEUS N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • ZEUS Metal Fabrications
  • Sector
  • RLMD Health Care
  • ZEUS Industrials
  • Exchange
  • RLMD Nasdaq
  • ZEUS Nasdaq
  • Market Cap
  • RLMD 289.7M
  • ZEUS 304.6M
  • IPO Year
  • RLMD N/A
  • ZEUS 1994
  • Fundamental
  • Price
  • RLMD $3.98
  • ZEUS $34.09
  • Analyst Decision
  • RLMD Hold
  • ZEUS Buy
  • Analyst Count
  • RLMD 2
  • ZEUS 1
  • Target Price
  • RLMD $1.00
  • ZEUS $38.00
  • AVG Volume (30 Days)
  • RLMD 1.8M
  • ZEUS 200.0K
  • Earning Date
  • RLMD 11-13-2025
  • ZEUS 10-28-2025
  • Dividend Yield
  • RLMD N/A
  • ZEUS 1.88%
  • EPS Growth
  • RLMD N/A
  • ZEUS N/A
  • EPS
  • RLMD N/A
  • ZEUS 1.17
  • Revenue
  • RLMD N/A
  • ZEUS $1,898,863,000.00
  • Revenue This Year
  • RLMD N/A
  • ZEUS $0.48
  • Revenue Next Year
  • RLMD N/A
  • ZEUS $2.77
  • P/E Ratio
  • RLMD N/A
  • ZEUS $29.04
  • Revenue Growth
  • RLMD N/A
  • ZEUS N/A
  • 52 Week Low
  • RLMD $0.24
  • ZEUS $26.32
  • 52 Week High
  • RLMD $4.34
  • ZEUS $43.60
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 78.00
  • ZEUS 56.12
  • Support Level
  • RLMD $2.42
  • ZEUS $32.98
  • Resistance Level
  • RLMD $2.86
  • ZEUS $35.02
  • Average True Range (ATR)
  • RLMD 0.43
  • ZEUS 1.88
  • MACD
  • RLMD 0.15
  • ZEUS 0.01
  • Stochastic Oscillator
  • RLMD 82.19
  • ZEUS 52.43

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About ZEUS Olympic Steel Inc.

Olympic Steel Inc provides metals processing and distribution services in the United States. The company operates in three reportable segments; specialty metals flat products, carbon flat products, and tubular and pipe products. It specializes in the processing and distribution of large volumes of carbon, aluminum, and stainless steel flat-rolled sheet, coils, plates, bars, and fabricated parts. The group serves various industries such as industrial machinery and equipment manufacturers, automobile manufacturers and suppliers, and transportation equipment manufacturers. The company generates majority of the revenue from carbon flat products.

Share on Social Networks: